World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
20706
World Ranking
19122
National Ranking
25

Shahin Akhondzadeh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Shahin Akhondzadeh sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 498 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Shahin Akhondzadeh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Shahin Akhondzadeh sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Shahin Akhondzadeh is affiliated with Tehran University of Medical Sciences in Iran. Their research spans multiple domains within medicine and neuroscience, with a particular focus on psychiatry and mental health. The main fields of study addressed by their work include Medicine and Neuroscience, with subfields that strongly emphasize Psychiatry and Mental Health, Pharmacology, Biological Psychiatry, Public Health, Environmental and Occupational Health, and Clinical Psychology.

Their scholarly output includes numerous publications across several notable medical journals. Frequent publication venues for Shahin Akhondzadeh include the Journal of Iranian Medical Council, Avicenna Journal of Medical Biotechnology, International Clinical Psychopharmacology, Psychiatry and Clinical Neurosciences, and Archives of Iranian Medicine.

The scientist's research portfolio covers a range of topics. Key areas of focus are Tryptophan and brain disorders, Treatment of Major Depression, Stress Responses and Cortisol, Bipolar Disorder and Treatment, Saffron Plant Research Studies, Autism Spectrum Disorder Research, and Genetics and Neurodevelopmental Disorders.

Frequent collaborators identified in their work comprise Ahmad Shamabadi, Hossein Sanjari Moghaddam, Kamyar Moradi, Alireza Hasanzadeh, and Sayna Bagheri.

Several recent papers highlight the scope of their research interests:

  • Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce, 2022, The World Journal of Biological Psychiatry
  • Victimization by traditional bullying and cyberbullying and the combination of these among adolescents in 13 European and Asian countries, 2021, European Child & Adolescent Psychiatry
  • Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial, 2020, Psychiatry and Clinical Neurosciences
  • Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial, 2020, Child Psychiatry & Human Development
  • Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: A randomized, double-blind, placebo-controlled clinical trial, 2021, Psychiatry and Clinical Neurosciences

Best Publications

  • Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.

    S Akhondzadeh;M Noroozian;M Mohammadi;S Ohadinia

  • Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial

    S Akhondzadeh;M Noroozian;M Mohammadi;S Ohadinia

  • Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial (ISRCTN45683816)

    Shahin Akhondzadeh;Hasan Fallah-Pour;Khosro Afkham;Amir-Hossein Jamshidi

  • Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam.

    Shahin Akhondzadeh;Hamid Reza Naghavi;M. Vazirian;A. Shayeganpour

  • Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

    Shahin Akhondzadeh;Sara Jafari;Firoozeh Raisi;Abbas Ali Nasehi

  • Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial

    Shahin Akhondzadeh;Najaf Tahmacebi-Pour;Ahamad-Ali Noorbala;Homayoun Amini

  • Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial

    A.A. Noorbala;S. Akhondzadeh;N. Tahmacebi-Pour;A.H. Jamshidi

  • Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.

    Afshin Akhondzadeh Basti;Esmail Moshiri;Ahamad-Ali Noorbala;Amir-Hossein Jamshidi

  • A 22-WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND CONTROLLED TRIAL OF CROCUS SATIVUS IN THE TREATMENT OF MILD-TO-MODERATE ALZHEIMER'S DISEASE

    Shahin Akhondzadeh;Mehdi Shafiee Sabet;Mohammad Hossein Harirchian;Mansoreh Togha

  • Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study

    Seyed-Hesameddin Abbasi;Fahimeh Hosseini;Amirhossein Modabbernia;Mandana Ashrafi

  • Celecoxib as adjunctive therapy in schizophrenia : A double-blind, randomized and placebo-controlled trial

    Shahin Akhondzadeh;Maryam Tabatabaee;Homayoun Amini;Seyed Ali Ahmadi Abhari

  • Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.

    Esmail Moshiri;Afshin Akhondzadeh Basti;Ahamad-Ali Noorbala;Amir-Hossein Jamshidi

  • Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16‐week, randomized and placebo‐controlled trial

    S. Akhondzadeh;M. Shafiee Sabet;M. H. Harirchian;M. Togha

  • Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]

    Shahin Akhondzadeh;Mohammad-Reza Mohammadi;Mojgan Khademi

  • Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial

    M Agha-Hosseini;L Kashani;A Aleyaseen;A Ghoreishi

  • Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial

    Shahin Akhondzadeh;Ladan Kashani;Akbar Fotouhi;Soghra Jarvandi

  • Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia

    Shahin Akhondzadeh;Farzin Rezaei;Bagher Larijani;Ali-Akbar Nejatisafa

  • Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial

    Amirhossein Modabbernia;Hamid Sohrabi;Abbas-Ali Nasehi;Firoozeh Raisi

  • Crocus sativus L. in the treatment of mild to moderate depression: A double-blind, randomised and placebo controlled trial

    AA Noorbala;N Tahmasebi-Pour;S Akhondzadeh;M Khani

  • Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial

    L Kashani;A Noorbala;S Akhondzadeh

Frequent Co-Authors

Trevor W. Stone
Trevor W. Stone University of Oxford
Reza Malekzadeh
Reza Malekzadeh Tehran University of Medical Sciences
Masud Yunesian
Masud Yunesian Tehran University of Medical Sciences
Amir Hossein Mahvi
Amir Hossein Mahvi Tehran University of Medical Sciences
Alireza Mesdaghinia
Alireza Mesdaghinia Tehran University of Medical Sciences
Michael Krausz
Michael Krausz University of British Columbia
Bagher Larijani
Bagher Larijani Tehran University of Medical Sciences
Ahmad Esmaillzadeh
Ahmad Esmaillzadeh Tehran University of Medical Sciences
Ali Akbar Haghdoost
Ali Akbar Haghdoost Kerman University of Medical Sciences
Michael Berk
Michael Berk Deakin University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending traditional on-campus programs. Many students choose online pathways to save time and money while reaching their goals. For those starting as registered nurses, there are cheapest rn to bsn online programs that offer an affordable and flexible route to earn a bachelor’s degree in nursing. This allows RNs to advance their qualifications without interrupting their work schedules.

If you already have a bachelor’s in nursing and want to move into leadership or research roles, accredited online phd nursing programs are available at more affordable rates than ever before. Many of these programs are designed to accommodate working professionals.

For those who want to fast-track their studies, cheapest online rn to bsn programs offer accelerated options. Additionally, non-nurses interested in advanced nursing roles can consider direct entry msn programs online, allowing motivated students to quickly enter the healthcare field.

Best Scientists Citing Shahin Akhondzadeh

Trending Scientists

Recently Published Articles